Who owns FATE THERAPEUTICS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of FATE from SEC Form 13F filings across 156 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 156 institutions disclosed 71.6M shares of FATE THERAPEUTICS INC worth $193.2M — about 59.5% of shares outstanding; the largest disclosed holder is Redmile Group, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
156
13F holders
$193.2M
value, 2026 filers
59.5%
of shares outstanding (71.6M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of FATE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Redmile Group, LLC | 12.9M | $34.8M | 2.3% | 10.7% | 0.0% |
| 2 | BlackRock, Inc. | 7.3M | $19.7M | 0.0% | 6.1% | -27.5% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5M | $12.3M | 0.0% | 3.8% | +9.9% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $12.0M | 0.0% | 3.7% | +6.0% |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 4.4M | $11.7M | 0.0% | 3.6% | +5.6% |
| 6 | AQR CAPITAL MANAGEMENT LLC | 3.8M | $10.4M | 0.0% | 3.2% | +27.8% |
| 7 | TWO SIGMA INVESTMENTS, LP | 3.6M | $9.7M | 0.0% | 3% | +3.6% |
| 8 | JOHNSON & JOHNSON | 3.4M | $9.1M | 1.1% | 2.8% | 0.0% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 3.0M | $8.1M | 0.0% | 2.5% | +0.3% |
| 10 | MILLENNIUM MANAGEMENT LLCNEW | 2.4M | $6.6M | 0.0% | 2% | new |
| 11 | GOLDMAN SACHS GROUP INC | 2.0M | $5.5M | 0.0% | 1.7% | +54.3% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $3.6M | 0.0% | 1.1% | -49.0% |
| 13 | T. Rowe Price Investment Management, Inc.NEW | 1.1M | $2.9M | 0.0% | 0.9% | new |
| 14 | JANE STREET GROUP, LLC | 1.0M | $2.8M | 0.0% | 0.9% | +58.7% |
| 15 | CITADEL ADVISORS LLC | 993,308 | $2.7M | 0.0% | 0.8% | +5.3% |
| 16 | Bruce & Co., Inc. | 989,188 | $2.7M | 0.7% | 0.8% | +25.3% |
| 17 | MORGAN STANLEY | 694,580 | $1.9M | 0.0% | 0.6% | -9.5% |
| 18 | VANGUARD FIDUCIARY TRUST CO | 640,428 | $1.7M | 0.0% | 0.5% | -2.0% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 610,949 | $1.6M | 0.0% | 0.5% | -19.2% |
| 20 | UBS Group AG | 590,178 | $1.6M | 0.0% | 0.5% | -67.6% |
| 21 | Qube Research & Technologies LtdNEW | 578,150 | $1.6M | 0.0% | 0.5% | new |
| 22 | Connor, Clark & Lunn Investment Management Ltd. | 574,995 | $1.6M | 0.0% | 0.5% | +22.4% |
| 23 | STATE STREET CORP | 558,928 | $1.5M | 0.0% | 0.5% | -75.3% |
| 24 | DAFNA Capital Management LLC | 525,000 | $1.4M | 0.3% | 0.4% | -4.5% |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 511,050 | $1.4M | 0.0% | 0.4% | +71.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.